Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

China Pharma Holdings (CPHI) Other Non Operating Income (2016)

China Pharma Holdings filings provide 5 years of Other Non Operating Income readings, the most recent being -$3324.0 for Q4 2016.

  • On a quarterly basis, Other Non Operating Income rose 78.06% to -$3324.0 in Q4 2016 year-over-year; TTM through Dec 2016 was $327871.0, a 80.01% decrease, with the full-year FY2016 number at $343023.0, down 79.09% from a year prior.
  • Other Non Operating Income hit -$3324.0 in Q4 2016 for China Pharma Holdings, down from -$2325.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $1.7 million in Q3 2015 to a low of -$15152.0 in Q4 2015.
  • Median Other Non Operating Income over the past 3 years was $27.0 (2014), compared with a mean of $292666.7.
  • The widest YoY moves for Other Non Operating Income: up 2443.84% in 2015, down 56218.52% in 2015.
  • China Pharma Holdings' Other Non Operating Income stood at $27.0 in 2014, then crashed by 56218.52% to -$15152.0 in 2015, then skyrocketed by 78.06% to -$3324.0 in 2016.
  • The last three reported values for Other Non Operating Income were -$3324.0 (Q4 2016), -$2325.0 (Q3 2016), and $348672.0 (Q2 2016) per Business Quant data.